Article
Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan…
bioRxiv · 2020 · Evgeniia Korotchenko
Key facts
| Title | Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma |
|---|---|
| First author | Evgeniia Korotchenko |
| Journal | bioRxiv |
| Published | Jan 18, 2020 |
| DOI | 10.1101/2020.01.18.911123 |
| Devices mentioned | K073490 |
| Product codes mentioned | CFN, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1